Cargando…
Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease
OBJECTIVE: To study the pathophysiological differences of EGPA and IgG(4)-related disease (RD) by clarifying their clinical, pathological and immunological features. METHODS: Clinical and pathological findings were compared in patients with EGPA and IgG(4)-RD. Peripheral blood mononuclear cells were...
Autores principales: | Kubo, Satoshi, Kanda, Ryuichiro, Nawata, Aya, Miyazaki, Yusuke, Kawabe, Akio, Hanami, Kentaro, Nakatsuka, Keisuke, Saito, Kazuyoshi, Nakayamada, Shingo, Tanaka, Yoshiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906049/ https://www.ncbi.nlm.nih.gov/pubmed/35260476 http://dx.doi.org/10.1136/rmdopen-2021-002086 |
Ejemplares similares
-
Granulomatosis with Polyangiitis Overlapping with IgG4-Related Disease
por: Pistone, Aureliano, et al.
Publicado: (2022) -
Increased IgG4-Positive Plasma Cells in Granulomatosis with Polyangiitis: A Diagnostic Pitfall of IgG4-Related Disease
por: Chang, Sing Yun, et al.
Publicado: (2012) -
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
por: Teixeira, Vítor, et al.
Publicado: (2019) -
Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
por: Merkel, Peter A., et al.
Publicado: (2021) -
Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis
por: Samson, Maxime, et al.
Publicado: (2023)